| Code | Description | Claims | Beneficiaries | Total Paid |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
26,217 |
2,052 |
$267K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
21,429 |
1,096 |
$34K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,333 |
848 |
$3K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
12,475 |
1,048 |
$903.53 |
| 82728 |
|
569 |
503 |
$651.31 |
| 82108 |
|
91 |
80 |
$130.40 |
| A4657 |
Syringe, with or without needle, each |
1,329 |
1,256 |
$0.00 |
| 83550 |
|
538 |
471 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
49 |
48 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
63 |
52 |
$0.00 |
| 90674 |
|
39 |
38 |
$0.00 |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
40 |
24 |
$0.00 |
| 82947 |
|
74 |
69 |
$0.00 |
| 83970 |
|
947 |
833 |
$0.00 |
| 85041 |
|
1,180 |
1,064 |
$0.00 |
| 85048 |
|
1,165 |
1,051 |
$0.00 |
| 83540 |
|
610 |
532 |
$0.00 |
| 85045 |
|
163 |
138 |
$0.00 |